Mortality in asymptomatic vs. symptomatic patients surgically treated for non-small cell lung cancer (NSCLC)

K. R. Madsen, U. Bodtger (Naestved, Copenhagen, Denmark)

Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Session: Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Session type: Thematic Poster Session
Number: 2876
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. R. Madsen, U. Bodtger (Naestved, Copenhagen, Denmark). Mortality in asymptomatic vs. symptomatic patients surgically treated for non-small cell lung cancer (NSCLC). Eur Respir J 2013; 42: Suppl. 57, 2876

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Surgical treatmment non-small cell lung cancer in the elderly patients
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015



Outcomes of radical treatment of early stage non-small cell lung cancer
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015


Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Major changes in men with non-small-cell lung cancer (NSCLC) in 10 years: The KBP-2000-CPHG and KBP-2010-CPHG cohorts
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013



Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Chemotherapy in elderly patients with non-small-cell lung cancer in Tunisian respiratory department
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013


Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC)
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Multiple primary malignancies in Japanese patients with non-small cell lung cancer
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013

Is there a difference in response to first line chemotherapy related to age in patients with locally advanced or metastatic non-small lung cancer?
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013


Adrenalectomy for isolated lesions in operable patients with non-small-cell lung cancer
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016

Is the lung cancer in elderly similar to lung cancer in younger patients?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

Risk factors for prolonged postoperative air leak-a retrospective analysis of 853 partial lung resections for non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013


The effect of surgical specimen-derived phosphorus and lead concentrations in non-small cell lung cancer patients on disease course
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

Cancer recurrence in surgically treated non small cell lung cancer (NSCLC)
Source: Eur Respir J 2006; 28: Suppl. 50, 755s
Year: 2006

Locoregional recurrence after pulmonary segmentectomy of non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013


Comorbitities, responses and survival in pts with NSCLC
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015